This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxo Group Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovative Work of Inventor Julien Bruno Douillet
Introduction: Julien Bruno Douillet, a talented inventor based in Stevenage, GB, has made significant contributions in the field of pharmaceuticals with his groundbreaking patent for an anti-inflammatory macrolide compound.
Latest Patents: Julien Bruno Douillet holds one patent for the compound 3'-N-demethyl-4″-O-(2-diethylaminoethanoyl)-6-O-methyl-9a-aza-9a-homoerythromycin A, designed for the treatment of neutrophil-dominated inflammatory diseases. This patent encompasses the compound, its compositions, applications, and production methods.
Career Highlights: Working at Glaxo Group Limited, Julien Bruno Douillet has showcased his expertise in pharmaceutical innovation. His dedication to developing novel solutions for inflammatory conditions has earned him recognition in the industry.
Collaborations: Julien Bruno Douillet has collaborated with skilled professionals in his field, including coworkers such as Caroline Jane Day and Darko Filic. These collaborations have enriched his work and contributed to the success of his inventions.
Conclusion: In conclusion, Julien Bruno Douillet stands out as a pioneering inventor in the pharmaceutical sector, with a patent that holds promise for improving the treatment of inflammatory diseases. His partnership with Glaxo Group Limited and collaborations with accomplished colleagues underscore his commitment to innovation and making a positive impact in the field of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile